InsiderTrades.com logo

ALLO Insider Trading

Insider Ownership Percentage: 13.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $665,452.11

Allogene Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Allogene Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Allogene Therapeutics Share Price & Price History

Current Price: $1.69
Price Change: ▼ Price Decrease of -0.04 (-2.31%)
As of 09/18/2026 04:00 PM ET

This chart shows the closing price history over time for ALLO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Allogene Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/21/2026Earl Martin DouglasSVPSell29,697$2.12$62,957.64488,267View SEC Filing Icon  
4/21/2026Annie YoshiyamaSVPSell9,586$2.31$22,143.66124,517View SEC Filing Icon  
3/31/2026Benjamin Machinas BeneskiSVPSell2,867$2.50$7,167.50195,338View SEC Filing Icon  
3/16/2026Benjamin Machinas BeneskiSVPSell4,835$2.47$11,942.45198,205View SEC Filing Icon  
3/16/2026David D. ChangCEOSell47,763$2.47$117,974.615,150,599View SEC Filing Icon  
3/2/2026Benjamin Machinas BeneskiSVPSell7,132$2.60$18,543.20203,040View SEC Filing Icon  
2/2/2026Annie YoshiyamaSVPSell4,167$1.72$7,167.24130,322View SEC Filing Icon  
2/2/2026Benjamin Machinas BeneskiSVPSell7,549$1.73$13,059.77210,172View SEC Filing Icon  
2/2/2026David D. ChangCEOSell95,269$1.80$171,484.205,185,862View SEC Filing Icon  
2/2/2026Earl Martin DouglasSVPSell22,900$1.76$40,304.00564,948View SEC Filing Icon  
2/2/2026Geoffrey M. ParkerCFOSell24,001$1.76$42,241.761,252,795View SEC Filing Icon  
2/2/2026Zachary RobertsEVPSell35,700$1.77$63,189.00581,166View SEC Filing Icon  
1/21/2026Zachary RobertsEVPSell26,269$1.56$40,979.64616,866View SEC Filing Icon  
10/21/2025Geoffrey M. ParkerCFOSell36,744$1.26$46,297.441,276,796View SEC Filing Icon  
4/21/2025Annie YoshiyamaSVPSell9,601$1.41$13,537.41130,663View SEC Filing Icon  
3/14/2025Benjamin Machinas BeneskiSVPSell5,488$1.98$10,866.24218,507View SEC Filing Icon  
3/14/2025David D. ChangCEOSell46,668$1.96$91,469.285,276,569View SEC Filing Icon  
2/3/2025Earl Martin DouglasSVPSell6,404$1.71$10,950.84587,848View SEC Filing Icon  
2/3/2025Geoffrey M. ParkerCFOSell4,361$1.73$7,544.531,301,540View SEC Filing Icon  
2/3/2025Timothy L MooreInsiderSell14,746$1.71$25,215.66250,713View SEC Filing Icon  
1/21/2025Zachary RobertsEVPSell27,199$1.78$48,414.22488,054View SEC Filing Icon  
12/9/2024Deborah M MessemerDirectorSell9,136$2.18$19,916.48157,629View SEC Filing Icon  
12/5/2024Franz B. HumerDirectorSell9,221$2.16$19,917.36307,507View SEC Filing Icon  
5/30/2024Franz B. HumerDirectorSell11,200$2.34$26,208.00255,253View SEC Filing Icon  
5/16/2024Arie BelldegrunDirectorBuy1,724,137$2.90$4,999,997.301,724,137View SEC Filing Icon  
1/30/2024Geoffrey M. ParkerCFOBuy190$3.60$684.00819,590View SEC Filing Icon  
12/18/2023Deborah M MessemerDirectorSell18,640$2.70$50,328.0062,456View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Allogene Therapeutics (NASDAQ:ALLO)

83.63% of Allogene Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALLO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Allogene Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026WINTON GROUP Ltd158,160$0.33M0.0%+30.5%0.046%Search for SEC Filing on Google Icon
9/9/2026Engineers Gate Manager LP98,511$0.21M0.0%-7.0%0.029%Search for SEC Filing on Google Icon
9/9/2026Squarepoint Ops LLC241,524$0.50M0.0%+107.5%0.070%Search for SEC Filing on Google Icon
8/27/2026Corient Private Wealth LP41,100$85K0.0%N/A0.012%Search for SEC Filing on Google Icon
8/23/2026Frazier Life Sciences Management L.P.22,446,668$46.69M1.0%+491.2%6.497%Search for SEC Filing on Google Icon
8/21/2026AXQ Capital LP83,217$0.17M0.0%+12.6%0.024%Search for SEC Filing on Google Icon
8/20/2026Headlands Technologies LLC205,453$0.43M0.0%-22.7%0.059%Search for SEC Filing on Google Icon
8/20/2026GTS Securities LLC13,220$27K0.0%N/A0.004%Search for SEC Filing on Google Icon
8/18/2026Coastal Bridge Advisors LLC21,789$45K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/18/2026Public Employees Retirement System of Ohio266,417$0.55M0.0%N/A0.077%Search for SEC Filing on Google Icon
8/17/2026Corient Private Wealth LP40,793$85K0.0%N/A0.012%Search for SEC Filing on Google Icon
8/17/2026Bank of America Corp DE3,187,320$6.63M0.0%N/A0.923%Search for SEC Filing on Google Icon
8/15/2026Man Group plc701,901$1.46M0.0%N/A0.203%Search for SEC Filing on Google Icon
8/14/2026Hsbc Holdings PLC259,747$0.56M0.0%N/A0.075%Search for SEC Filing on Google Icon
8/14/2026Primecap Management Co. CA13,123,440$27.30M0.0%N/A3.802%Search for SEC Filing on Google Icon
8/14/2026Canada Pension Plan Investment Board115,500$0.24M0.0%N/A0.033%Search for SEC Filing on Google Icon
8/14/2026Legal & General Group Plc25,743$54K0.0%N/A0.007%Search for SEC Filing on Google Icon
8/14/2026The Manufacturers Life Insurance Company426,274$0.89M0.0%N/A0.124%Search for SEC Filing on Google Icon
8/14/2026Partners Capital Investment Group LLP161,597$0.34M0.0%N/A0.047%Search for SEC Filing on Google Icon
8/14/2026Algert Global LLC122,420$0.26M0.0%-73.6%0.035%Search for SEC Filing on Google Icon
8/13/2026Connor Clark & Lunn Investment Management Ltd.322,827$0.67M0.0%N/A0.094%Search for SEC Filing on Google Icon
8/13/2026Bank of Nova Scotia97,400$0.20M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/12/2026Quantbot Technologies LP116,933$0.24M0.0%N/A0.034%Search for SEC Filing on Google Icon
8/12/2026Ieq Capital LLC580,371$1.21M0.0%N/A0.168%Search for SEC Filing on Google Icon
8/11/2026E Fund Management Co. Ltd.47,593$99K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/7/2026BlackRock Inc.30,146,963$62.71M0.0%N/A8.734%Search for SEC Filing on Google Icon
8/7/2026Pallas Capital Advisors LLC11,844$25K0.0%N/A0.003%Search for SEC Filing on Google Icon
8/7/2026Deutsche Bank AG281,949$0.59M0.0%N/A0.082%Search for SEC Filing on Google Icon
8/7/2026Mitsubishi UFJ Asset Management Co. Ltd.547,189$1.14M0.0%N/A0.159%Search for SEC Filing on Google Icon
8/6/2026Bank of New York Mellon Corp727,182$1.51M0.0%N/A0.211%Search for SEC Filing on Google Icon
8/6/2026State of Wyoming33,840$70K0.0%N/A0.010%Search for SEC Filing on Google Icon
8/6/2026GSA Capital Partners LLP285,590$0.59M0.0%N/A0.083%Search for SEC Filing on Google Icon
8/3/2026Walleye Capital LLC3,268,012$6.80M0.0%N/A0.947%Search for SEC Filing on Google Icon
7/9/2026Hennion & Walsh Asset Management Inc.722,928$1.50M0.0%N/A0.209%Search for SEC Filing on Google Icon
7/8/2026Westmount Partners LLC36,000$75K0.0%N/A0.010%Search for SEC Filing on Google Icon
5/21/2026Essential Partners LLC19,410$47K0.0%+525.9%0.008%Search for SEC Filing on Google Icon
5/19/2026Bank of America Corp DE2,134,473$5.21M0.0%+111.9%0.872%Search for SEC Filing on Google Icon
5/19/2026Bull Harbor Capital LLC12,703$31K0.0%N/A0.005%Search for SEC Filing on Google Icon
5/18/2026Royal Bank of Canada56,532$0.14M0.0%+15.9%0.023%Search for SEC Filing on Google Icon
5/16/2026The Manufacturers Life Insurance Company654,180$1.60M0.0%+35.0%0.267%Search for SEC Filing on Google Icon
5/14/2026Renaissance Technologies LLC2,139,328$5.22M0.0%-2.2%0.874%Search for SEC Filing on Google Icon
5/14/2026Public Employees Retirement System of Ohio177,875$0.43M0.0%N/A0.073%Search for SEC Filing on Google Icon
5/7/2026Dimensional Fund Advisors LP1,201,655$2.93M0.0%+25.5%0.491%Search for SEC Filing on Google Icon
5/5/2026Bank of New York Mellon Corp395,187$0.96M0.0%-2.6%0.161%Search for SEC Filing on Google Icon
5/1/2026Candriam S.C.A.2,997,318$7.31M0.0%+30.0%1.224%Search for SEC Filing on Google Icon
4/30/2026Hsbc Holdings PLC260,404$0.64M0.0%+75.8%0.106%Search for SEC Filing on Google Icon
4/30/2026Harold Davidson & Associates Inc.289,222$0.71M0.3%+48.5%0.118%Search for SEC Filing on Google Icon
4/29/2026R Squared Ltd45,245$0.11M0.1%-47.5%0.018%Search for SEC Filing on Google Icon
4/28/2026Abel Hall LLC26,647$65K0.0%+56.4%0.011%Search for SEC Filing on Google Icon
4/20/2026Kestra Private Wealth Services LLC10,909$27K0.0%N/A0.004%Search for SEC Filing on Google Icon
4/17/2026Krilogy Financial LLC16,780$40K0.0%N/A0.007%Search for SEC Filing on Google Icon
4/16/2026SG Americas Securities LLC15,390$38K0.0%-35.8%0.006%Search for SEC Filing on Google Icon
3/20/2026Hsbc Holdings PLC148,136$0.20M0.0%+57.5%0.061%Search for SEC Filing on Google Icon
3/3/2026Caitong International Asset Management Co. Ltd44,334$61K0.0%+84.4%0.020%Search for SEC Filing on Google Icon
2/23/2026Virtu Financial LLC42,351$58K0.0%+55.9%0.019%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.609,807$0.84M0.0%+16.1%0.271%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV29,512$40K0.0%+23.0%0.013%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd476,307$0.65M0.0%-38.5%0.212%Search for SEC Filing on Google Icon
2/18/2026Zacks Investment Management192,731$0.26M0.0%-63.4%0.086%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC176,178$0.24M0.1%+116.8%0.078%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd274,416$0.38M0.0%+15.3%0.122%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC1,841,307$2.52M0.0%-45.7%0.819%Search for SEC Filing on Google Icon
2/18/2026Man Group plc526,106$0.72M0.0%+86.5%0.234%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC1,429,247$1.96M0.0%-22.9%0.636%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD3,209,275$4.40M0.0%-12.7%1.428%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.40,041$55K0.0%+83.3%0.018%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors53,101$73K0.0%+237.9%0.024%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada48,794$67K0.0%-95.6%0.022%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.148,671$0.20M0.0%-24.7%0.066%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC104,656$0.14M0.0%-61.0%0.047%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC642,687$0.88M0.0%+7.3%0.286%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP285,561$0.39M0.0%N/A0.127%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co50,951$69K0.0%+28.2%0.023%Search for SEC Filing on Google Icon
2/13/2026Kalehua Capital Management LLC2,546,129$3.49M3.2%N/A1.133%Search for SEC Filing on Google Icon
2/13/2026Smartleaf Asset Management LLC28,927$38K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/13/2026Headlands Technologies LLC46,778$64K0.0%-66.6%0.021%Search for SEC Filing on Google Icon
2/13/2026OpenArc Corporate Advisory LLC162,984$0.22M0.0%N/A0.073%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.1,355,809$1.86M0.0%+16.4%0.603%Search for SEC Filing on Google Icon
2/13/2026State Street Corp2,761,400$3.78M0.0%+0.2%1.229%Search for SEC Filing on Google Icon
2/13/2026Ieq Capital LLC435,267$0.60M0.0%+15.7%0.194%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN200,276$0.27M0.0%+38.3%0.089%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP72,751$99K0.0%-45.1%0.032%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC34,823$48K0.0%-39.2%0.015%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC2,187,084$3M0.0%-24.4%0.973%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP957,816$1.31M0.0%-54.2%0.426%Search for SEC Filing on Google Icon
2/12/2026Patient Square Capital LP4,963,756$6.80M1.5%+66.5%2.209%Search for SEC Filing on Google Icon
2/11/2026Primecap Management Co. CA8,139,840$11.15M0.0%+15.0%3.622%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG131,086$0.18M0.0%-6.9%0.058%Search for SEC Filing on Google Icon
2/11/2026Cerity Partners LLC97,909$0.13M0.0%-79.0%0.044%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC170,750$0.23M0.0%-3.8%0.076%Search for SEC Filing on Google Icon
2/11/2026Harold Davidson & Associates Inc.194,753$0.27M0.1%-34.1%0.087%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.2,289,458$3.14M0.0%+90.2%1.019%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC86,637$0.12M0.0%+20.5%0.039%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC3,932,910$5.39M0.0%+2.6%1.750%Search for SEC Filing on Google Icon
2/6/2026GSA Capital Partners LLP613,998$0.84M0.1%+235.7%0.273%Search for SEC Filing on Google Icon
2/5/2026Navalign LLC49,398$68K0.0%-17.5%0.022%Search for SEC Filing on Google Icon
1/30/2026R Squared Ltd86,215$0.12M0.1%+40.5%0.038%Search for SEC Filing on Google Icon
1/23/2026Choreo LLC38,849$51K0.0%N/A0.017%Search for SEC Filing on Google Icon
1/16/2026Aberdeen Group plc2,086,332$2.86M0.0%+31.9%0.928%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.908,725$1.13M0.0%-2.7%0.404%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Allogene Therapeutics logo
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma; and is in Phase 1b clinical trial for the treatment of chronic lymphocytic leukemia. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase 1 clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO-316, an allogeneic CAR T cell product candidate that is in Phase 1 clinical trial for the treatment of advanced or metastatic RCC; ALLO-329 for the treatment of certain autoimmune diseases; DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors; and Claudin 18.2 for the treatment of gastric and pancreatic cancer. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.
Read More on Allogene Therapeutics

Today's Range

Now: $1.69
Low: $1.67
High: $1.74

50 Day Range

MA: $1.92
Low: $1.66
High: $2.23

52 Week Range

Now: $1.69
Low: $1.04
High: $4.46

Volume

12,716,730 shs

Average Volume

4,813,760 shs

Market Capitalization

$583.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of Allogene Therapeutics?

Allogene Therapeutics' top insider shareholders include:
  1. David D Chang (CEO)
  2. Arie Belldegrun (Director)
  3. Geoffrey M Parker (CFO)
  4. Zachary Roberts (EVP)
  5. Earl Martin Douglas (SVP)
  6. Veer Bhavnagri (General Counsel)
  7. Rafael Amado (CMO)
  8. Franz B Humer (Director)
  9. Timothy L Moore (Insider)
  10. Owen N Witte (Director)
Learn More about top insider investors at Allogene Therapeutics.

Who are the major institutional investors of Allogene Therapeutics?

Allogene Therapeutics' top institutional shareholders include:
  1. BlackRock Inc. — 8.73%
  2. Frazier Life Sciences Management L.P. — 6.50%
  3. Primecap Management Co. CA — 3.80%
  4. Walleye Capital LLC — 0.95%
  5. Bank of America Corp DE — 0.92%
  6. Bank of New York Mellon Corp — 0.21%
Learn More about top institutional investors of Allogene Therapeutics stock.

Which institutional investors are selling Allogene Therapeutics stock?

During the previous quarter, ALLO stock was sold by these institutional investors:
  1. Algert Global LLC
  2. Headlands Technologies LLC
  3. Engineers Gate Manager LP
Within the previous year, company insiders that have sold Allogene Therapeutics company stock include:
  1. David D Chang (CEO)
  2. Geoffrey M Parker (CFO)
  3. Zachary Roberts (EVP)
  4. Earl Martin Douglas (SVP)
  5. Benjamin Machinas Beneski (SVP)
  6. Annie Yoshiyama (SVP)
Learn More investors selling Allogene Therapeutics stock.

Which institutional investors are buying Allogene Therapeutics stock?

During the previous quarter, ALLO stock was acquired by institutional investors including:
  1. BlackRock Inc.
  2. Frazier Life Sciences Management L.P.
  3. Primecap Management Co. CA
  4. Walleye Capital LLC
  5. Bank of America Corp DE
  6. Bank of New York Mellon Corp
  7. Hennion & Walsh Asset Management Inc.
  8. Man Group plc

Allogene Therapeutics Active Insiders

David D Chang
David D Chang
President, Chief Executive Officer and Co-Founder
Geoffrey M Parker
Geoffrey M Parker
Executive Vice President, Chief Financial Officer
Zachary Roberts
Zachary Roberts
Executive Vice President, Research & Development, Chief Medical Officer
Owen N Witte
Owen N Witte (Age 75)
Director
Arie Belldegrun
Arie Belldegrun (Age 77)
Director
Franz B Humer
Franz B Humer
Director
Stephen Mayo
Stephen Mayo
Director
Veer Bhavnagri
Veer Bhavnagri (Age 43)
General Counsel
Annie Yoshiyama (Age 42)
SVP
1 recent trades
Earl Martin Douglas
Earl Martin Douglas
SVP
1 recent trades
Benjamin Machinas Beneski
Benjamin Machinas Beneski (Age 49)
SVP
1 recent trades
Rafael Amado
Rafael Amado (Age 62)
CMO